Detection of Ryanodine receptor antibody in sera of myasthenia gravis patients and its clinical significance

Xiang Zhang,Jian Qiao,Chuanzhen Lü
2003-01-01
Abstract:Objective: To evaluate the significance to detect the Ryanodine receptor (RyR) antibody in the sera of myasthenia gravis (MG) patients. Methods: Sarcoplasmic reticulum abound with RyR was extracted by centrifugation, and levels of antibodies in 66 MG patients with thymoma (MGT), 98 non-thymoma MG (NTMG) patients, 50 non-myasthenia gravis (NMG) patients and 123 normal persons were examined by ELISA-RyR method. Results: RyR antibody positive rate of MGT was the highest among MGT, NTMG and NMG groups (P < 0.01), the sensitivity was 81.8% while the speciality was 94.5%. The positive rates of MGT groups with different thymus histology had no statistic differences (P > 0.05). Ages, clinical scores and levels of acetycholine receptor antibodies of patients with RyR antibody positive sera were higher than those with RyR antibody negative sera (P < 0.01). The levels of RyR had positive correlation with the severities of MG patients, especially MGT (r = 0. 626, P < 0.01), and MGT with thymoma of epithelioid cells had the highest correlation coefficient (r = 0. 592, P < 0.01). Conclusion: The detection of RyR antibody has better sensitivity and speciality in examining the MGT patients, and the levels of that antibody have positive correlation with the severities of MG patients.
What problem does this paper attempt to address?